Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey

Nav

General Info

Geography

United States of America (USA)

Georgia (GEO)

Time period covered

01/2020 - 12/2020

Data type

Scientific literature

Keywords

COVID-19

Citation

Authors

Journal

Clin Infect Dis

Publication year

2020

Suggested citation

Bajema KL, Dahlgren FS, Lim TW, Bestul N, Biggs HM, Tate JE, Owusu C, Szablewski CM, Drenzek C, Drobeniuc J, Semenova V, Li H, Browning P, Desai R, Epperson M, Jia LT, Thornburg NJ, Edens C, Fry AM, Hall AJ, Schiffer J, Havers FP. Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey. Clin Infect Dis. 2020.

DOI

10.1093/cid/ciaa1804

PMID

33300579

GHDx Entry last modified on: Jan 31, 2024

Header sites

Search form

Main menu

Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey

Nav